IASO-206

N/A

Report date: 2026/05/14 20:00:28

Base Information

Drug NameIASO-206

Drug Alias NameIASO206IASO-206

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy > In vivo CAR-T therapyCell and gene therapy > Cell therapy > In vivo cell therapy > In vivo CAR-T therapy

Mechanisms of ActionB-cell maturation protein modulatorsT lymphocyte replacements

TargetsB-cell maturation protein

Therapy Area/IndicationsAnemia, Hemolytic, AutoimmuneMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Hematology & Blood Diseases Hospital

China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Hematology & Blood Diseases Hospital

Inactive CompaniesN/A

Active IndicationsAnemia, Hemolytic, AutoimmuneMultiple Myeloma

Inactive IndicationsN/A

Other Information

ATC CodeN/A